CompletedNot Applicable

Osteosarcopenia and Exercise

Turkey (Türkiye)27 participantsStarted 2018-12-03

Plain-language summary

The purpose of this study is to assess the efficacy of combination of aerobic and resistive exercise on activities of daily living and risk of fall in osteosarcopenic patients

Who can participate

Age range70 Years – 91 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Over 70 years of age * Clinical diagnosis of osteoporosis or osteopenia * Independent mobilization * Walking speed \< 0.8 m / sec * Grip strength \< 20 kg for women, \< 30 kg for men Exclusion Criteria: * Uncontrolled hypertension (systolic blood pressure\> 200 mmHg, diastolic blood pressure\> 110 mmHg) * Uncontrolled diabetes mellitus * Stroke, hip fracture, knee and hip arthroplasty, spinal surgery in the last 6 months * Severe cardiac arrhythmia * Myocardial infarction in the last 6 months * Severe dementia and difficulties in cooperation * Cardiac pacemaker * Dialysis * Acute infection * Severe edema * Malignancy patients * Severe anemia (Hgb \<8 mg / dl)

What they're measuring

Change from Baseline on Skeletal Muscle Mass Measurement at month 3

Timeframe: Baseline and Month 3

Change from Baseline on Skeletal Muscle Mass Measurement at month 1

Timeframe: Baseline and Month 1

Change from Baseline on Katz Activities of Daily Living Scale at month 3

Timeframe: Baseline and Month 3

Change from Baseline on Katz Activities of Daily Living Scale at month 1

Timeframe: Baseline and Month 1

Change from Baseline on Short Physical Performance Battery at month 3

Timeframe: Baseline and Month 3

Change from Baseline on Short Physical Performance Battery at month 1

Timeframe: Baseline and Month 1

Change from Baseline on Berg Balance Test at month 3

Timeframe: Baseline and Month 3

Change from Baseline on Berg Balance Test at month 1

Timeframe: Baseline and Month 1

Trial details

NCT IDNCT04526327

SponsorSisli Hamidiye Etfal Training and Research Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-03-03

View on ClinicalTrials.gov More Sarcopenia trials

Who can participate

Age range70 Years – 91 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change from Baseline on Skeletal Muscle Mass Measurement at month 3

Timeframe: Baseline and Month 3

Change from Baseline on Skeletal Muscle Mass Measurement at month 1

Timeframe: Baseline and Month 1

Change from Baseline on Katz Activities of Daily Living Scale at month 3

Timeframe: Baseline and Month 3

Change from Baseline on Katz Activities of Daily Living Scale at month 1

Timeframe: Baseline and Month 1

Change from Baseline on Short Physical Performance Battery at month 3

Timeframe: Baseline and Month 3

Change from Baseline on Short Physical Performance Battery at month 1

Timeframe: Baseline and Month 1

Change from Baseline on Berg Balance Test at month 3

Timeframe: Baseline and Month 3

Change from Baseline on Berg Balance Test at month 1

Timeframe: Baseline and Month 1